(olodaterol hydrochloride + tiotropium bromide)
Marketedupdated 2mo agoby Boehringer Ingelheim Corp
Approvedcommunity read0 votes
indications
investigational
COPD
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that